Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 184
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can Data Management Tools Improve Research Efficiency and Reproducibility?

    Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

    How Do Fats Help Us Treat Brain Cancer?

    Malignant Brain Tumors will kill over 13,000 cancer patients this year in the United States alone; brain tumors...

    Can we use our immune cells to fight lung disease?

    Acute respiratory distress syndrome (ARDS) is a common deadly illness often seen in the intensive care unit...

    Backer Badge Funded